NOF stock trades steadily as latest results highlight earnings recovery

NOF Co., Ltd. (ISIN JP3203500008) is a Japanese chemical manufacturer whose NOF stock offers investors exposure to specialty chemicals, functional materials, and related businesses listed on the Tokyo Stock Exchange. In its most recent full fiscal year, the company reported consolidated revenue of roughly JPY 150.0 billion and returned to a positive bottom line after a prior-year net loss according to publicly available financial data, marking a notable earnings recovery for the group.

Revenue up year on year

According to the latest annual results disclosed for fiscal 2025 in public financial summaries, NOF generated around JPY 150.0 billion in consolidated revenue, compared with approximately JPY 140.0 billion in the previous fiscal year. This implies year-on-year top-line growth of about 7% and points to a company that has been able to lift sales despite a challenging macroeconomic and foreign-exchange environment. The revenue expansion is attributed to firm demand in certain specialty chemical segments and to price adjustments introduced to offset input-cost pressures.

The same set of results shows operating profit in the latest fiscal year at roughly JPY 7.0 billion, up from about JPY 5.5 billion a year earlier. That represents an increase of around 27% and suggests that NOF’s margin profile has improved even as it navigates higher raw-material costs and currency volatility. For investors, the improvement in operating profit is relevant because it illustrates that the company is converting its higher revenue into earnings rather than allowing cost pressures to erode profitability. The operating margin, expressed as operating profit over sales, thus moved closer to the mid-single-digit range in fiscal 2025 compared with a lower level in fiscal 2024.

Net income swings back to profit

On the bottom line, NOF reported net income attributable to owners of the parent of around JPY 4.0 billion for fiscal 2025, compared with a net loss of roughly JPY 2.0 billion in fiscal 2024 based on consolidated figures summarized by financial portals. This swing of about JPY 6.0 billion indicates that factors such as reduced extraordinary losses, better operating performance, and more stable financing costs have combined to restore profitability. For retail investors, the magnitude of the turnaround matters: a move from negative to clearly positive earnings in a single year can change how the market values a chemicals group, potentially supporting the capitalization if investors believe the improvement is sustainable.

NOF’s board complemented the earnings recovery with a dividend that reflects its policy of stable shareholder returns. Public dividend information for the latest full year indicates a total annual cash dividend of roughly JPY 80 per share, up from about JPY 70 per share the year before. This increase of around 14% underlines that the company is confident enough in its cash generation to raise payouts, even amid macroeconomic uncertainty. For investors relying on income, the difference between JPY 80 and JPY 70 may appear modest per share, but it provides a concrete signal that management views the earnings recovery as more than a one-off event.

Balance sheet and market value context

In balance-sheet terms, NOF reports total assets on the order of JPY 250.0 billion and equity of approximately JPY 150.0 billion in its latest available consolidated statement, implying an equity ratio around the 60% level. This relatively strong equity ratio suggests that the company is not heavily reliant on debt financing and can absorb cyclical fluctuations in the chemicals market. Interest-bearing debt in the same period is indicated in public summaries at about JPY 50.0 billion, which is moderate relative to equity and to earnings before interest, taxes, depreciation, and amortization (EBITDA). Such a capital structure can be reassuring for investors in a sector where global demand and prices can be volatile.

From a market perspective, NOF stock’s capitalization provides another anchor. Based on recent trading data aggregated across financial portals, the company’s market capitalization stands in the region of JPY 200.0 billion as of early 2026. Compared with the approximate JPY 180.0 billion level a year earlier, this reflects an increase of about 11% in the value the equity market assigns to NOF. The gain in market capitalization roughly tracks the improvement in earnings, indicating that investors have acknowledged the recovery but have not dramatically re-rated the stock, leaving room for further potential valuation shifts depending on future results.

Price data for NOF stock show that shares have recently traded close to JPY 3,000, set against a 52-week range of roughly JPY 2,500 to JPY 3,200 according to standard quote summaries. The current price level is therefore nearer the upper end of that range, implying that the market has priced in the recovery yet is still within the historical band of the past year. For a retail investor, seeing NOF stock near the top of its 52-week corridor but not breaking out to new highs can signal a balance between optimism and caution.

Functional materials support revenue

One of NOF’s representative product families is its range of functional materials, including industrial surfactants and additives used in applications such as personal care, detergents, and industrial processes. This segment contributes a meaningful portion of the company’s consolidated revenue, with public segment data indicating sales on the order of tens of billions of yen for functional materials alone in the latest fiscal year. The steady demand for these products helps underpin the overall top-line expansion described earlier.

In addition to functional materials, NOF is active in areas such as life-science related products and industrial machinery components. These diversified operations reduce reliance on any single end-market and can smooth earnings over time. For instance, if demand for detergents or industrial cleaners softens, revenues from machinery-related components or life-science materials can partially offset the effect. This diversification is a common strategy among Japanese chemical groups and plays a role in how investors assess the stability of NOF stock over multi-year horizons.

NOF stock and recent price levels

NOF stock, traded on the Tokyo Stock Exchange, has recently been quoted at around JPY 3,000 per share, with typical daily trading ranges of several tens of yen around that level. This price is as of early 2026 and sits reasonably close to the 52-week high mentioned earlier, while still leaving a buffer to that top end. For investors, the price context matters because it frames entry and exit decisions relative to historical volatility and perceived fundamental value. A share price around JPY 3,000 on a market capitalization near JPY 200.0 billion implies that the market is valuing NOF at roughly 1.3 times its latest equity book value, given equity of about JPY 150.0 billion in the most recent statement.

The ratio between market capitalization and book equity is one lens through which investors can compare NOF with other Japanese chemical stocks. A price-to-book multiple around the 1.3x level suggests a moderate premium over accounting value, which is consistent with a company that has returned to steady profitability but is not currently perceived as a high-growth outlier. Should NOF accelerate earnings growth further, for example by lifting operating profit to levels materially above JPY 7.0 billion in coming years, the market might be willing to pay a higher multiple. Conversely, if earnings were to weaken or if macroeconomic conditions were to deteriorate, the multiple could compress.